Transgender hormone therapy (male-to-female) males is associated with higher serum estrogen. Both estrogen and testosterone help to stimulate bone formation, especially during puberty. Estrogen is the predominant sex hormone that slows bone loss, even in men. In spite of the induction of breast development, transgender women who undergo HRT do not have an increased risk of breast cancer. Only a handful of cases of breast cancer have ever been described in transgender women who have undergone male-to-female HRT. This is in accordance with research in cisgender men in which gynecomastia has been found not to be associated with an increased risk of breast cancer,
Body odour and sexual attraction psychological studies that women’s preferences for various male traits change throughout the menstrual cycle. Hormonal fluctuation across the menstrual cycle explains temporal variation in women’s judgment of the attractiveness of members of the opposite sex. This is due to the psychological processes that shape the formation and maintenance of human romantic relationships are influenced by variation in hormonal levels. Due to their high hormone content, oral contraceptives have the potential to alter women’s partner preference for a range of male traits, which could have important consequences on sexual relationships, as it alters women’s attraction to their partner and, potentially, to